Rationale:
Condyloma acuminata and anogenital warts are protruding papillomatous lesions caused by human papillomavirus. In pregnant women, condyloma acuminata over the cervical region may grow rapidly, mimicking cervical cancer.
Patient concerns:
A pregnant woman at 14 weeks of gestation with condyloma acuminatum mimicking cervical cancer was referred to our hospital for further management.
Diagnosis:
Condyloma acuminata.
Interventions:
Tumor biopsy was performed twice, and the pathology confirmed condyloma acuminatum. Immunohistochemistry revealed focal positivity for p16 and Ki-67. Cryotherapy was performed and regular follow-up was performed at 2-week intervals. A small residual condyloma acuminata was found and treated with cryotherapy.
Outcome:
During the follow-up period, no recurrence of condyloma acuminata was noted. She delivered a baby at 37 weeks of gestation via cesarean section, without complications.
Lessons:
Condyloma acuminata of the cervix may grow faster during pregnancy, mimicking cervical cancer. Multiple factors must be considered when treating condyloma acuminata during pregnancy. Cryotherapy is proposed as a 1st-line treatment in all trimesters because of its safety, convenience, and cost-effectiveness. Serial follow-up at 2-week intervals to observe post-cryotherapy conditions is recommended.
Keywords: cervical cancer, condyloma, cryotherapy, pregnancy
1. Introduction
Condyloma acuminata is an anogenital wart caused by human papillomavirus (HPV) infection.[1] HPV infection is mainly transmitted through sexual behavior. The development of condyloma acuminata can be affected by lifestyle, age, and sexual activity.
More than 100 HPV serotypes have been identified to date. Low-risk HPV serotypes 6 and 11 are the most common types that cause condyloma acuminata.[1] High-risk HPV (types 16 and 18) can cause cervical cancer in women.[2]
The prevalence of HPV infection ranges from 9% to 13% globally. It is also the most common sexually transmitted infection worldwide.[3] Adults aged between 20 and 39 years of age are mostly infected.[4] The risk factors for HPV infection include multiple sexual partners, a history of gonorrhea or chlamydia infections, human immunodeficiency virus infection, and smoking.[5] The incidence of anogenital warts is 1.1 to 1.2 per 1000 person-years.[6]
Condyloma acuminata may be asymptomatic or present with symptoms such as itching, pain, and vaginal bleeding.[7] Condyloma acuminata may be discovered for the 1st time during regular perinatal examinations during pregnancy. Pregnant women with condyloma acuminata have a higher chance of vertical mother-to-child transmission.[8] Therefore, it is important to treat condyloma acuminata in pregnant women to decrease the possibility of vertical transmission.[8]
Condyloma acuminata in pregnant women tends to proliferate significantly, possibly due to physiological changes in the external genitalia and the partially immunocompromised status of pregnancy, which allows for the rapid replication of HPV.[9] Owing to the downregulation of cell-mediated immunity in pregnancy, pregnant women are prone to have large condyloma acuminata lesions.[9] Apart from the symptoms caused by condyloma acuminata, obstetric complications may include hemorrhage-related impaired wound repair and increased neonatal HPV infection.[9]
Multiple treatment options are available for condyloma acuminata. Topical agents, surgical excision, electrocauterization, and cryotherapy are treatment options for condyloma.[8] Cryotherapy is inexpensive, less painful, and safe; thus, it is recommended as 1st-line therapy in pregnancy.[10,11]
We report the case of a pregnant woman with cervical condyloma mimicking cervical cancer, which was discovered at 14 weeks of gestation and treated with cryotherapy. The baby was delivered via cesarean section because of a previous surgical scar.
2. Case report
A 34-years-old pregnant woman presented to our outpatient clinic at 14 weeks of gestation with a chief complaint of a small amount of vaginal bleeding for 2 weeks. The patient was admitted to another hospital where cervical malignancy was suspected, and further evaluation at our medical center was suggested.
Upon examination, she denied having trauma or engaging in recent sexual activity. She denied any known systemic disease, uterine or vaginal structural abnormalities, or medication use. She denied alcohol, betel nut, and cigarette consumption. She was a social worker in a nearby town and denied travel or contact history of respiratory disease. She had had a pregnancy 3 years before this evaluation, which was accompanied with uncomplicated hypertension. The previous delivery was performed at 37 weeks at a hospital due to a premature membrane rupture noted during a routine examination. The planned normal spontaneous delivery was switched to cesarean section because of prolonged labor and breech presentation.
Vaginal examination showed a protruding cauliflower-like cervical tumor measuring 2.5 centimeters, with easy contact bleeding (Fig. 1A). Pelvic ultrasound showed a 2.5-centimeter cervical hypoechoic mass (Fig. 1B). She reported normal annual pap smear results in the previous 2 years and denied having multiple sexual partners. A colposcopic biopsy was performed, and pathology showed possible squamous cell carcinoma (SCC); however, further confirmation was required. Pelvic magnetic resonance imaging was performed 2 days later, but the lesion was too subtle to be defined (Fig. 1C). No apparent lymphadenopathy or metastasis in the pelvic region was observed on imaging. The levels of tumor markers [carcinoembryonic antigen, SCC, CA125, and CA19-9] were all within normal limits.
Figure 1.
Gross image, ultrasound, and magnetic resonance image (MRI) of the condyloma acuminata. (A) Gross image of the condyloma acuminata. The tumor was 3.5 cm in diameter at the cervical region. (B) Ultrasound of the cervical condyloma acuminata (hypoechoic lesion, arrow). (C) T2 MRI of the cervical condyloma acuminata (arrow). MRI = magnetic resonance image.
Because of the suspected SCC of the cervix, we performed a repeat cervical biopsy. Pathological examination showed condyloma acuminatum (Fig. 2A and B). Immunohistochemistry revealed p16 focal positivity (30%) (Fig. 2C) and mild-to-moderately increased Ki-67 expression (Fig. 2D). Consequently, she underwent cryotherapy to eradicate the lesion at 16 weeks of gestation. She was followed up at our outpatient clinic every 2 weeks. A small condyloma lesion was noted 1 month later, and she underwent a second cryotherapy. The following course of the pregnancy was uneventful, except for gestational diabetes mellitus, and diet control was suggested. She underwent cesarean section at 37 weeks of gestation, and the baby was delivered uneventfully.
Figure 2.
Histopathology and immunohistochemistry of the condyloma acuminata. (A) H&E staining of the condyloma (50×). (B) Magnification of (A) (200×). (C) Immunohistochemistry of p16 (brown color, 200×). (D) Immunohistochemistry of Ki67 (brown color, 100×).
3. Discussion
Various clinical conditions and management strategies for condylomas during pregnancy have been reported in the literature. Condyloma may be large and undiagnosed until the patient presents for delivery. The neonate may be delivered through a normal vaginal delivery or cesarean section if insufficient vaginal stretching with possible obstruction is suspected.[8] Surgical excision of large lesions before delivery is seldom considered reasonable management because the fetus may be affected during anesthesia.[12,13]
In the present case, the patient 1st visited another hospital, where the lesion was highly likely to be malignant. The lesion showed risky features, including rapid outgrowth and contact bleeding, during her 1st visit to our outpatient clinic. A diagnosis of cervical SCC was considered until the pathology report confirmed that the lesion was a condyloma acuminata. To the best of our knowledge, this is the 1st case report of a condyloma mimicking cancer.
The treatment options for condyloma acuminatum can be divided into patient-applied and provider-applied methods.[14] The former indicates the use of topical imiquimod,[15] and the latter mainly includes laser therapy, cryotherapy, photodynamic therapy, and local hyperthermia.[16] Cryotherapy is recommended as the 1st-line therapy because it does not require anesthesia; thus, management in an outpatient setting is possible. Moreover, the risks of local complications and danger to the fetus are low.[11] Laser therapy is recommended as second-line therapy because all lesions can be treated in 1 session, especially extensive lesions.[8]
Vertical mother-to-child transmission of HPV can occur in children born via a cesarean section.[17] If no other indications for cesarean delivery are present, prophylactic cesarean section may have limited benefits. However, treating maternal condyloma lesions is important to decrease the overall HPV viral load.[8]
p16 and Ki-67 double immunostaining is used to detect high-grade squamous intraepithelial lesions (SIL).[18] The p16 and Ki-67 staining intensities gradually increase as lesions progress from low-grade to high-grade SIL.[19] Diffuse staining for p16 is a marker of high-grade SIL and is not associated with HPV infections.[20] p16 and Ki-67 positivity is associated with histologic severity.[21] Our case showed focal positivity for p16 and Ki-67, and no SIL was found.
A limitation of this report was that it included only 1 case, which may not be representative of other cases. Our case report indicates that condyloma can mimic cervical cancer, but the possibility of cervical cancer even in the presence of condyloma should still be considered.
4. Conclusion
Our case showed a large cervical condyloma that mimicked cervical cancer. After pathological confirmation, the condyloma was diagnosed and treated with cryotherapy. Finally, the patient delivered a healthy baby. Our case suggests that pathological confirmation is essential for a condyloma diagnosis. A reasonable treatment plan can be determined if the correct diagnosis is made. We chose cryotherapy for condyloma owing to its convenience and the non-requirement for anesthesia. Serial follow-up after cryotherapy is important for determining treatment efficacy and the need for further treatment sessions. In our case, follow-up every 2 weeks was arranged to monitor for recurrence. The second cryotherapy session was conducted because of a small lesion during regular follow-up. The delivery was through cesarean section due to a previous scar; however, if no other factors exist, vaginal delivery may also be reasonable in a completely treated case of condyloma.
Author contributions
Conceptualization: Dah-Ching Ding.
Data curation: Kai-Chieh Chang, Yen-Chang Chen, Dah-Ching Ding.
Formal analysis: Kai-Chieh Chang, Dah-Ching Ding.
Investigation: Yen-Chang Chen.
Supervision: Dah-Ching Ding.
Writing – original draft: Kai-Chieh Chang, Dah-Ching Ding.
Writing - review & editing: Dah-Ching Ding.
Abbreviations:
- HPV =
- human papillomavirus
- SCC =
- squamous cell carcinoma
- SIL =
- squamous intraepithelial lesions
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
The authors have no funding and conflicts of interest to disclose.
Written informed consent was obtained from the patient for the publishing of this paper.
How to cite this article: Chang K-C, Chen Y-C, Ding D-C. Condyloma acuminatum mimicking cervical cancer in a pregnant woman and treatment with cryotherapy: A case report. Medicine 2022;101:49(e32273).
Contributor Information
Kai-Chieh Chang, Email: cysh102210714@gmail.com.
Yen-Chang Chen, Email: s92312129@gmail.com.
References
- [1].O’Mahony C, Gomberg M, Skerlev M, et al. Position statement for the diagnosis and management of anogenital warts. J Eur Acad Dermatol Venereol. 2019;33:1006–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Ding DC, Hsu HC, Huang RL, et al. Type-specific distribution of HPV along the full spectrum of cervical carcinogenesis in Taiwan: an indication of viral oncogenic potential. Eur J Obstet Gynecol Reprod Biol. 2008;140:245–51. [DOI] [PubMed] [Google Scholar]
- [3].Tyros G, Mastraftsi S, Gregoriou S, et al. Incidence of anogenital warts: epidemiological risk factors and real-life impact of human papillomavirus vaccination. Int J STD AIDS. 2021;32:4–13. [DOI] [PubMed] [Google Scholar]
- [4].Sindhuja T, Bhari N, Gupta S. Asian guidelines for condyloma acuminatum. J Infect Chemother. 2022;28:845–52. [DOI] [PubMed] [Google Scholar]
- [5].Goldstone S, Palefsky JM, Giuliano AR, et al. Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. J Infect Dis. 2011;203:66–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Park IU, Introcaso C, Dunne EF. Human papillomavirus and genital warts: a review of the evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis. 2015;61(Suppl 8):S849–55. [DOI] [PubMed] [Google Scholar]
- [7].Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1–137. [PMC free article] [PubMed] [Google Scholar]
- [8].Sugai S, Nishijima K, Enomoto T. Management of condyloma acuminata in pregnancy: a review. Sex Transm Dis. 2021;48:403–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Suzuki S, Sekizawa A, Tanaka M, et al. Current status of condylomata acuminata in pregnant Japanese women. Jpn J Infect Dis. 2016;69:347–9. [DOI] [PubMed] [Google Scholar]
- [10].Scheinfeld N. Update on the treatment of genital warts. Dermatol Online J. 2013;19:18559. [PubMed] [Google Scholar]
- [11].Yang LJ, Zhu DN, Dang YL, et al. Treatment of condyloma acuminata in pregnant women with cryotherapy combined with proanthocyanidins: outcome and safety. Exp Ther Med. 2016;11:2391–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Choudhary N, Verma S, Gandhi S, et al. A rare case of giant condyloma acuminata during pregnancy. Int J Reprod Contracept Obstet Gynecol. 2022;11:2562–4. [Google Scholar]
- [13].Cui T, Huang J, Lv B, et al. Giant condyloma acuminatum in pregnancy: a case report. Dermatol Ther. 2019;32:e12972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].Eriad Yunir P, Mochtar CA, Hamid ARAH, et al. Surgical management of giant genital condyloma acuminata by using double keystone flaps. Case Rep Urol. 2016;2016:4347821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Ciavattini A, Tsiroglou D, Vichi M, et al. Topical imiquimod 5% cream therapy for external anogenital warts in pregnant women: report of four cases and review of the literature. J Matern Fetal Neonatal Med. 2012;25:873–6. [DOI] [PubMed] [Google Scholar]
- [16].Yang YG, Zou XB, Zhao H, et al. Photodynamic therapy of condyloma acuminata in pregnant women. Chin Med J. 2012;125:2925–8. [PubMed] [Google Scholar]
- [17].Lee SM, Park JS, Norwitz ER, et al. Risk of vertical transmission of human papillomavirus throughout pregnancy: a prospective study. PLoS One. 2013;8:e66368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [18].Ahmed S, Obaseki D, Mayun A, et al. The role of biomarkers (p16INK4a and Ki-67) in cervical cancer screening: an appraisal. Ann Trop Pathol. 2017;8:1. [Google Scholar]
- [19].Popiel A, Piotrowska A, Sputa-Grzegrzolka P, et al. Preliminary study on the expression of testin, p16 and Ki-67 in the cervical intraepithelial neoplasia. Biomedicines. 2021;9:1010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Zhang G, Yang B, Abdul-Karim FW. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing. Int J Gynecol Pathol. 2015;34:180–6. [DOI] [PubMed] [Google Scholar]
- [21].Yu LL, Chen W, Lei XQ, et al. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China. Oncotarget. 2016;7:21181–9. [DOI] [PMC free article] [PubMed] [Google Scholar]


